Since its creation, with the support of European Commission, O4CP has built a strong pipeline of projects in the area of cancer, immune and neonate diseases.

As development of new medicines for children require such a broad range of skills and competencies, a strong and diverse consortium is conducting each project.

A summary of project and the link to their dedicated website is presented herafter:

• Loulla&Philla: This European project funded by the EC FP7 concerns the development of oral liquid formulation of methotrexate and mercaptopurine for the treatment of the acute lymphoblastic leukemia.

• NEMO: This Global project funded by the EC FP7 concerns the development of bumetanide for the treatment of neonatal epilepsy.

• Forms4kids: This French Project include the development of five molecules for immune, cardiovascular and neurological diseases.